TELA Bio, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for TELA Bio, Inc. (TELA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are TELA insiders buying or selling?
In the last 12 months, TELA Bio, Inc. insiders reported 5 open-market purchases ($4.2M) and 0 sales ($0) — net buying of $4.2M. Since November 2019, Trabud has recorded 106 Form 4 filings for TELA: 103 buys ($51.9M) and 3 sells ($4.2M).
Source: SEC EDGAR Form 4
Key Statistics (November 2019 – Sep 18, 2026)
Total Form 4 filings
106
SEC EDGAR
Insider filers
14
Insider buys (103)
$51.9M
Insider sells (3)
$4.2M
Insider sentiment
Net buyingNet insider flow of $47.7M in net buying since November 2019, and $4.2M in net buying over the last 12 months. 4 insider buys in the last 90 days.
Recent TELA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Joseph H Capper | Director | Purchase | 75.0K | $1.18 | $88.8K | SEC ↗ |
| Sep 16, 2026 | Joseph H Capper | Director | Purchase | 75.0K | $1.05 | $78.4K | SEC ↗ |
| Aug 19, 2026 | Heather C Getz | Chief Executive Officer | Purchase | 12.5K | $0.66 | $8.3K | SEC ↗ |
| Aug 17, 2026 | Heather C Getz | Chief Executive Officer | Purchase | 15.0K | $0.70 | $10.5K | SEC ↗ |
| Nov 17, 2025 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Other, 10% Owner | Purchase | 3.6M | $1.11 | $4.0M | SEC ↗ |
| Oct 24, 2024 | Roberto Cuca | COO and CFO | Purchase | 64.4K | $2.25 | $145.0K | SEC ↗ |
| Oct 24, 2024 | Paul Talmo | Chief Technology Officer | Purchase | 22.2K | $2.25 | $50.0K | SEC ↗ |
| Oct 24, 2024 | Antony Koblish | Chief Executive Officer | Purchase | 88.9K | $2.25 | $200.0K | SEC ↗ |
| Oct 24, 2024 | Gregory A. Firestone | Chief Commercial Officer | Purchase | 6.7K | $2.25 | $15.0K | SEC ↗ |
| Jul 2, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 428.3K | $4.72 | $2.0M | SEC ↗ |
| Feb 16, 2024 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Other, 10% Owner | Purchase | 326.1K | $9.32 | $3.0M | SEC ↗ |
| Dec 7, 2023 | Gregory A. Firestone | Chief Business Officer | Purchase | 2.6K | $5.65 | $14.7K | SEC ↗ |
| Nov 15, 2023 | Roberto Cuca | COO and CFO | Purchase | 10.0K | $4.49 | $44.9K | SEC ↗ |
| Nov 15, 2023 | Antony Koblish | Chief Executive Officer | Purchase | 11.0K | $4.54 | $50.0K | SEC ↗ |
| Apr 21, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 192.0K | $9.34 | $1.8M | SEC ↗ |
| Nov 4, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 20.3K | $7.81 | $158.3K | SEC ↗ |
| Oct 11, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 16.0K | $8.00 | $128.0K | SEC ↗ |
| Sep 26, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 6.8K | $7.99 | $54.4K | SEC ↗ |
| Sep 19, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 18.0K | $8.09 | $145.6K | SEC ↗ |
| Sep 16, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 6.5K | $8.09 | $52.9K | SEC ↗ |
| Sep 15, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 5.2K | $8.10 | $42.3K | SEC ↗ |
| Aug 19, 2022 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Other | Purchase | 500.0K | $8.00 | $4.0M | SEC ↗ |
| Aug 16, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 315.0K | $8.00 | $2.5M | SEC ↗ |
| Aug 12, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 5.0K | $7.96 | $39.6K | SEC ↗ |
| Aug 12, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 12.0K | $8.52 | $102.1K | SEC ↗ |
Showing the 25 most recent of 106 Form 4 filings for TELA Bio, Inc..
Most active TELA insiders
- EW HEALTHCARE PARTNERS FUND 2, L.P.65 filings
- Opaleye Management Inc.18 filings
- Roberto Cuca5 filings
- ORBIMED ADVISORS LLC3 filings
- Antony Koblish2 filings
Ask anything about TELA insider activity
Use Trabud's AI agent to query TELA Bio, Inc.'s Form 4 history in plain English — "Show me TELA CEO purchases this year" or compare it against any other ticker.
Open the AI agentTELA insider trading FAQ
Are TELA Bio, Inc. insiders buying or selling?
In the last 12 months, TELA Bio, Inc. insiders reported 5 open-market purchases ($4.2M) and 0 sales ($0) — net buying of $4.2M. Since November 2019, Trabud has recorded 106 Form 4 filings for TELA: 103 buys ($51.9M) and 3 sells ($4.2M). Over the full record that is net buying of $47.7M.
How many insiders trade TELA stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TELA Bio, Inc.. The most recent filing was accepted on Sep 18, 2026.
Where does Trabud get TELA insider trading data?
All TELA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.